Background: Cytokeratins are epithelial markers whose expression is not lost during malignant transformation. Cyfra 21-1 is a cytokeratin-19 fragment that is soluble in serum and may be a useful circulating tumor marker. Study objective: The aims of this study were (1) to con¬ firm sensitivity and specificity of Cyfra 21-1 in detecting non-small cell lung cancer (NSCLC) and especially the squamous cell subtype, (2) (Fig 1) . For At the threshold of 3.3 ng/mL, sensitivity was 40.9% and specificity was 94.4%. CEA and NSE had a limited ability to predict either NSCLC (Fig 1) or squamous cell carcinoma (Fig 2) 
